Inspira Technologies Oxy BHN Ltd Ordinary Shares IINN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Inspira™ Launches INSPIRA™ ART100 at the World's Largest Extracorporeal Life Support Conference
-
Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System
-
Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024
-
Inspira™ Technologies Announces FDA Listing and Market Readiness of New Product
-
Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 - Results Exceed 100% at Maximum Flow
-
Inspira™ Technologies Introduces the INSPIRA Cardi-ART, Aiming to Provide Oxygen to the Brain During Cardiac Arrest
-
Inspira™ Receives Israeli Regulatory Approval for the INSPIRA™ ART100 System
Trading Information
- Previous Close Price
- $1.39
- Day Range
- $1.30–1.47
- 52-Week Range
- $0.76–2.49
- Bid/Ask
- $1.27 / $1.42
- Market Cap
- $25.35 Mil
- Volume/Avg
- 336,598 / 106,794
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 42
Valuation
|
Metric
|
IINN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.73 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
IINN
|
|---|---|
Quick Ratio | 0.98 |
Current Ratio | 2.23 |
Interest Coverage | −24.49 |
Quick Ratio
IINN
Profitability
|
Metric
|
IINN
|
|---|---|
Return on Assets (Normalized) | −97.54% |
Return on Equity (Normalized) | −154.81% |
Return on Invested Capital (Normalized) | −127.40% |
Return on Assets
IINN
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Qwhgmxj | Vcmmzms | $198.4 Bil | |||
| Stryker Corp
SYK
| Mmpnvqmfw | Xfk | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Bgxhzcs | Wqlswp | $123.4 Bil | |||
| Medtronic PLC
MDT
| Wflpnnrph | Zwrdcr | $115.5 Bil | |||
| Edwards Lifesciences Corp
EW
| Txswcqwzc | Kbgys | $39.8 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Gkcq | Tlns | $30.6 Bil | |||
| DexCom Inc
DXCM
| Glftrmcm | Jzy | $26.9 Bil | |||
| Steris PLC
STE
| Lblhqmc | Fjzhy | $23.9 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Zppyfcgk | Qgtr | $22.0 Bil | |||
| Insulet Corp
PODD
| Wxhgbcmgn | Bcvnzf | $16.3 Bil |
United States